Amgen Criticizes Draft Report Before Publication

Amgen is criticizing ICER’s assessments in a recent draft report that hasn’t even been published yet. Find out more here. (Source: Jaimy Lee, MM&M, 4/5/16)

You might also be interested in:

Relentless Health Value’s Richter, #HCBiz Show!’s… August 2, 2018
Study: ICER Value Assessments Could Leave Medicare Part B… June 2, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
ICER CSO Ollendorf Stepping Down July 4, 2018
ICER Releases Report on Antiandrogen Therapies for… August 25, 2018
ICER Names Athelia Tilson as VP of Development December 1, 2018
Amgen to Use BC Platforms’ Data Solutions in… January 10, 2018